Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen expands operations into Brazil
Yahoo/AP
Friday, April 8, 2011 - 11:05am
tags:
Amgen, Brazil
J&J picks Torres to deal with McNeil nitty-gritty
Fierce Pharma
Friday, April 8, 2011 - 11:01am
tags:
JNJ, recalls, McNeil, Denice Torres
Pfizer Sutent Drug May Help Patients With Jobs’s Type of Cancer
Bloomberg
Friday, April 8, 2011 - 10:59am
tags:
Pfizer, Sutent, kidney cancer, pancreatic cancer
Impax Labs in capsule drug partnership with Banner
Yahoo/AP
Friday, April 8, 2011 - 10:58am
tags:
Impax, Banner Pharmacaps, capsules
Merck Loses U.K. Appeal Against Teva to Reinstate Cosopt Patent
Bloomberg
Friday, April 8, 2011 - 10:57am
tags:
Merck, Teva Pharmaceuticals, UK, Cosopts, patents
Biotech Stock Mailbag: Hep C Stock Winners
TheStreet.com
Friday, April 8, 2011 - 10:56am
tags:
hepatitis C, Pharmasset, Merck, Optimer, Vertex Pharmaceuticals, Gilead Sciences, JNJ, InterMune, Bristol-Myers Squibb
Amgen Chairman and CEO received $21 million in 2010 compensation, up 38 percent from 2009
Yahoo/AP
Friday, April 8, 2011 - 10:54am
tags:
Amgen, executive pay, Kevin Sharer
Roche's T-DM1 Treatment Halted Spread of Breast Cancer in Mid-Stage Study
Bloomberg
Friday, April 8, 2011 - 9:53am
tags:
Roche, breast cancer, T-DM1
FDA To Roche: Our Advisory Panel Is Not Biased
Pharmalot
Friday, April 8, 2011 - 9:40am
tags:
Roche, FDA, advisory panels, Avastin
Cephalon Recommends Shareholders Reject Valeant Nominees
Yahoo
Friday, April 8, 2011 - 9:38am
tags:
Cephalon, Valeant Pharmaceuticals, M&A, shareholders
AstraZeneca Drug Approved! But Where's the Name?
Motley Fool
Friday, April 8, 2011 - 9:35am
tags:
AstraZeneca, vandetanib, thyroid cancer
Labor Dept Wants Rehearing On Overtime For Reps (DOL files in support of two GSK reps)
Pharmalot
Thursday, April 7, 2011 - 5:22pm
tags:
overtime lawsuits, GSK
Glaxo Said to Be Among Three Bidders for Turkey’s Biofarma
Bloomberg
Thursday, April 7, 2011 - 5:17pm
tags:
GSK, M&A, Turkey, Biofarma
Alcon shareholders approve sale to Novartis
Yahoo/AP
Thursday, April 7, 2011 - 5:16pm
tags:
Alcon, Novartis, M&A
Endo Pharmaceuticals Widens Reach As Star Drug Fades
Investor's Business Daily
Thursday, April 7, 2011 - 5:15pm
tags:
Endo, lidoderm
Shire, Watson in Legal Battle
Yahoo/Zacks.com
Thursday, April 7, 2011 - 5:14pm
tags:
Watson Pharmaceuticals, Shire, Adderall XR, patents
Novartis sells skin drug to Meda for $420 mln
Reuters
Thursday, April 7, 2011 - 1:42pm
tags:
Meda, Novartis, Elidel
Analyst: J&J may need a $10B-plus deal
Fierce Pharma
Thursday, April 7, 2011 - 1:41pm
tags:
JNJ, M&A
Biotech: Top 3 Analyst Picks
Seeking Alpha
Thursday, April 7, 2011 - 1:39pm
tags:
Elan, Protalix BioTherapeutics, InterMune
How Many Patients Would Switch To Generics?
Pharmalot
Thursday, April 7, 2011 - 10:09am
tags:
generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.